novo nordisk glp-1 patent litigation Ozempic's problem: how lost control of a blockbuster drug. 💉 Demand for weight-loss drugs has exploded, turning Ozempic into a $40bn+ revenue engine for Novo Nordisk. But, despite Lawsuits claiming Ozempic, other GLP-1s

Kidney-targeted nanoparticles loaded with the natural antioxidant rosmarinic acid for acute kidney injury treatment

(July 2012)

But with the desire for even greater convenience, a new question is emerging: What about a patch

GHK-Cu (99% purity, lyophilized) is employed across a range of in vitro and preclinical research applications where its copper-coordinating and gene-regulatory properties are under investigation

I was put on steroids and antihistamines, but they didnt do much, until I started implementing a sulfur protocol (that I have since perfected and now use to help people reverse sulfur issues and many cases of egg sensitivity!)